MedTrace Logo

Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer

NCT04389424 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-05-15

No results posted yet for this study

Summary

The protocol involves measurement of 25 hidroxy vitamin D, gene expression of cytochrome and vitamin D receptor , endoxifen, tamoxifen, exemestane, and other metobolites related to nutrition and endocrine metabolism.

Conditions

  • Breast Cancer
  • Endocrine Therapy
  • Endocrine Therapy Adverse Reaction
  • Vitamin D Deficiency
  • Nutrition Disorders
  • Obesity

Interventions

DRUG

Tamoxifen

Use of tamoxifen for breast cancer recurrence prevention

DRUG

Exemestane

Use of exemestane for breast cancer recurrence prevention

DRUG

Anastrozole

Use of anastrozole for breast cancer recurrence prevention

DIAGNOSTIC_TEST

Basal

Initial diagnosis of breast cacner by biopsy or mastectomy

DIAGNOSTIC_TEST

Recurrence

Breast cancer recurrence under endocrine therapy

Sponsors & Collaborators

  • University of Guadalajara

    collaborator OTHER

  • Instituto Jalisciense de Cancerologia

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
98 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2020-05-15
Completion
2022-01-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04389424 on ClinicalTrials.gov